Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-15 McKenzie Paul EVP Pharmaceutical Oper & Tech Shares withheld for taxes −643 $332.87 $214K 7,324.63
2019-02-15 McKenzie Paul EVP Pharmaceutical Oper & Tech Option exercise · Restricted Stock Unit −1,448 3,226
2019-02-15 McKenzie Paul EVP Pharmaceutical Oper & Tech Other disposition · Restricted Stock Unit −888 2,338
2019-02-15 Ehlers Michael D EVP, Research and Development Option exercise +1,685 8,526.17
2019-02-15 Ehlers Michael D EVP, Research and Development Shares withheld for taxes −749 $332.87 $249K 7,777.17
2019-02-15 Ehlers Michael D EVP, Research and Development Option exercise · Restricted Stock Unit −1,685 3,757
2019-02-15 Ehlers Michael D EVP, Research and Development Other disposition · Restricted Stock Unit −1,033 2,724
2019-02-15 ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. Option exercise +1,685 28,776
2019-02-15 ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. Shares withheld for taxes −749 $332.87 $249K 28,027
2019-02-15 ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. Option exercise · Restricted Stock Unit −1,685 3,757
2019-02-15 ALEXANDER SUSAN H EVP Chief Legal Officer & Sec. Other disposition · Restricted Stock Unit −1,033 2,724
2019-02-14 Posner Brian S Director Gift −315 6,895
2019-02-12 Vounatsos Michel Chief Executive Officer Option exercise +6,899 16,267.27
2019-02-12 Vounatsos Michel Chief Executive Officer Shares withheld for taxes −2,622 $319.43 $838K 13,645.27
2019-02-12 Vounatsos Michel Chief Executive Officer Option exercise · Restricted Stock Unit −6,899 29,421
2019-02-12 Vounatsos Michel Chief Executive Officer Other disposition · Restricted Stock Unit −5,205 24,216
2019-02-12 Vounatsos Michel Chief Executive Officer Grant or award · Restricted Stock Unit +37,570 37,570
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Option exercise +1,104 7,732.19
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Shares withheld for taxes −358 $319.43 $114K 7,374.19
2019-02-12 Sandrock Alfred EVP, Chief Medical Officer Shares withheld for taxes −588 $319.43 $188K 6,786.19

Page 51 of 61 · 1,204 trades